{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:40Z","timestamp":1792787920522,"version":"4.5.0"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Helsinki","id":[{"id":"https:\/\/ror.org\/040af2s02","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Meningiomas are the most frequently reported primary brain and other central nervous system tumors and account for more than one-third of all primary CNS tumors. High-grade meningiomas (WHO grades 2 and 3) are associated with significantly poorer prognosis and a higher risk of recurrence than grade 1 tumors, despite surgery and radiotherapy. Although several genetic and epigenetic alterations, including\n                    <jats:italic>NF2<\/jats:italic>\n                    inactivation and related molecular drivers, have been identified in these tumors, effective systemic treatment options remain limited. Increasing evidence indicates that the Wnt\/\u03b2-catenin signaling pathway is altered in meningiomas, as demonstrated by dysregulated expression of \u03b2-catenin, pathway regulators, and downstream transcriptional activity in different studies. Mechanistic studies in meningioma models show that Merlin S13 dephosphorylation, rather than Merlin loss alone, can attenuate inhibitory Merlin\u2013\u03b2-catenin interactions, promote \u03b2-catenin-dependent Wnt signaling, and support tumor growth in\n                    <jats:italic>NF2<\/jats:italic>\n                    -wildtype meningiomas. Because the Wnt pathway regulates key processes such as proliferation, differentiation, apoptosis resistance, and tumor microenvironment interactions, its dysregulation may contribute to meningioma progression, particularly in biologically aggressive or higher-grade tumors. A better understanding of these mechanisms may help identify more rational therapeutic approaches for aggressive meningiomas. However, their clinical relevance will depend on whether candidate strategies can achieve adequate tumor exposure while maintaining acceptable systemic and CNS safety.\n                  <\/jats:p>","DOI":"10.1186\/s12935-026-04393-1","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:15:33Z","timestamp":1784895333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Wnt signaling networks in higher-grade meningiomas: from molecular pathogenesis to therapeutic innovation"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6772-178X","authenticated-orcid":false,"given":"Arathy S.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Tynninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miikka","family":"Korja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"Supplement4","key":"4393_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","volume":"27","author":"M Price","year":"2025","unstructured":"Price M, Ballard CAP, Benedetti JR, Kruchko C, Barnholtz-Sloan JS, Ostrom QT. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2018\u20132022. Neuro Oncol. 2025;27(Supplement4):iv1\u2013iv66. https:\/\/doi.org\/10.1093\/neuonc\/noaf194.","journal-title":"Neuro Oncol"},{"key":"4393_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.579599","volume":"10","author":"K Huntoon","year":"2020","unstructured":"Huntoon K, Toland AMS, Dahiya S. Meningioma: A Review of Clinicopathological and Molecular Aspects. Front Oncol. 2020;10:579599. https:\/\/doi.org\/10.3389\/fonc.2020.579599","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"4393_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/biomedicines9030319","volume":"9","author":"C Ogasawara","year":"2021","unstructured":"Ogasawara C, Philbrick BD, Adamson DC. Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions. Biomedicines. 2021;9(3):319. https:\/\/doi.org\/10.3390\/biomedicines9030319.","journal-title":"Biomedicines"},{"key":"4393_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00701-026-06908-1","volume":"168","author":"MN Pamir","year":"2026","unstructured":"Pamir MN, Er\u015fen-Danyeli A, \u00d6zduman K. Current evidence on the cell of origin of meningiomas disputes the arachnoid cap cell dogma. Acta Neurochir. 2026;168:114. https:\/\/doi.org\/10.1007\/s00701-026-06908-1","journal-title":"Acta Neurochirurgica"},{"key":"4393_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41388-020-01568-6","volume":"40","author":"DM Fountain","year":"2021","unstructured":"Fountain DM, Smith MJ, O\u2019Leary C, et al. The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges. Oncogene. 2021;40:875\u201384. https:\/\/doi.org\/10.1038\/s41388-020-01568-6.","journal-title":"Oncogene"},{"issue":"4","key":"4393_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3892\/br.2025.1934","volume":"22","author":"EK Dwianingsih","year":"2025","unstructured":"Dwianingsih EK, Krisnugraha YP, Bawono RG, Malueka RG. Molecular biomarkers in meningioma (Review). Biomed Rep. 2025;22(4):56. https:\/\/doi.org\/10.3892\/br.2025.1934.","journal-title":"Biomed Rep"},{"key":"4393_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-804280-9.00001-9","volume":"169","author":"KM Walsh","year":"2020","unstructured":"Walsh KM. Epidemiology of meningiomas. Handb Clin Neurol. 2020;169:3\u201315. https:\/\/doi.org\/10.1016\/B978-0-12-804280-9.00001-9.","journal-title":"Handb Clin Neurol"},{"key":"4393_CR8","unstructured":"WHO Classification of Tumours Editorial Board. Central Nervous System Tumours. WHO Classification of Tumours, 5th ed, vol. 6. Lyon (France): International Agency for Research on Cancer. 2021. ISBN: 978-92-832-4508-7. Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/45"},{"issue":"8","key":"4393_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol"},{"key":"4393_CR10","doi-asserted-by":"publisher","first-page":"1137849","DOI":"10.3389\/fonc.2023.1137849","volume":"13","author":"V Yarabarla","year":"2023","unstructured":"Yarabarla V, Mylarapu A, Han TJ, McGovern SL, Raza SM, Beckham TH. Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy. Front Oncol. 2023;13:1137849. https:\/\/doi.org\/10.3389\/fonc.2023.1137849.","journal-title":"Front Oncol"},{"issue":"2","key":"4393_CR11","doi-asserted-by":"publisher","first-page":"WVJZ9783","DOI":"10.47795\/WVJZ9783","volume":"22","author":"A Clynch","year":"2023","unstructured":"Clynch A, Richardson GE, Mustafa MA, Gillespie CS, Rathi N, Bakhsh A, Zakaria R, Islim AI, Millward CP, Jenkinson MD. Beyond the WHO classification of meningioma: using molecular diagnostics to guide management. Adv Clin Neurosci Rehabil. 2023;22(2):WVJZ9783. https:\/\/doi.org\/10.47795\/WVJZ9783.","journal-title":"Adv Clin Neurosci Rehabil"},{"issue":"2","key":"4393_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3174\/ajnr.A8368","volume":"46","author":"N Soni","year":"2025","unstructured":"Soni N, Ora M, Bathla G, Szekeres D, Desai A, Pillai JJ, Agarwal A. Meningioma: Molecular Updates from the 2021 World Health Organization Classification of CNS Tumors and Imaging Correlates. AJNR Am J Neuroradiol. 2025;46(2):240\u201350. https:\/\/doi.org\/10.3174\/ajnr.A8368.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4393_CR13","doi-asserted-by":"publisher","first-page":"154340","DOI":"10.1016\/j.prp.2023.154340","volume":"243","author":"RA Franca","year":"2023","unstructured":"Franca RA, Della Monica R, Corvino S, Chiariotti L, Del Basso De Caro M. WHO grade and pathological markers of meningiomas: Clinical and prognostic role. Pathol Res Pract. 2023;243:154340. https:\/\/doi.org\/10.1016\/j.prp.2023.154340.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"4393_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11060-022-04148-8","volume":"161","author":"MJ Mair","year":"2023","unstructured":"Mair MJ, Berghoff AS, Brastianos PK, Preusser M. Emerging systemic treatment options in meningioma. J Neurooncol. 2023;161(2):245\u201358. https:\/\/doi.org\/10.1007\/s11060-022-04148-8.","journal-title":"J Neurooncol"},{"key":"4393_CR15","doi-asserted-by":"publisher","unstructured":"Bi WL, Dunn IF. Current and emerging principles in surgery for meningioma. Chin Clin Oncol. 2017;6(Suppl 1):S7. https:\/\/doi.org\/10.21037\/cco.2017.06.10","DOI":"10.21037\/cco.2017.06.10"},{"key":"4393_CR16","doi-asserted-by":"publisher","first-page":"851758","DOI":"10.3389\/fonc.2022.851758","volume":"12","author":"B Patel","year":"2022","unstructured":"Patel B, Desai R, Pugazenthi S, Butt OH, Huang J, Kim AH. Identification and Management of Aggressive Meningiomas. Front Oncol. 2022;12:851758. https:\/\/doi.org\/10.3389\/fonc.2022.851758.","journal-title":"Front Oncol"},{"key":"4393_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41525-017-0014-7","volume":"2","author":"WL Bi","year":"2017","unstructured":"Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, Ducar M, Thorner AR, van Hummelen P, Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R. Genomic landscape of high-grade meningiomas. NPJ Genom Med. 2017;2:15. https:\/\/doi.org\/10.1038\/s41525-017-0014-7.","journal-title":"NPJ Genom Med"},{"issue":"4","key":"4393_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1215\/15228517-2007-026","volume":"9","author":"A Maillo","year":"2007","unstructured":"Maillo A, Orfao A, Espinosa AB, Sayagu\u00e9s JM, Merino M, Sousa P, Lara M, Tabernero MD. Early recurrences in histologically benign\/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. Neuro Oncol. 2007;9(4):438\u201346. https:\/\/doi.org\/10.1215\/15228517-2007-026.","journal-title":"Neuro Oncol"},{"issue":"5","key":"4393_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/neuonc\/not325","volume":"16","author":"PH Domingues","year":"2014","unstructured":"Domingues PH, Sousa P, Otero \u00c1, Gon\u00e7alves JM, Ruiz L, de Oliveira C, Lopes MC, Orfao A, Tabernero MD. Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype. Neuro Oncol. 2014;16(5):735\u201347. https:\/\/doi.org\/10.1093\/neuonc\/not325.","journal-title":"Neuro Oncol"},{"issue":"5","key":"4393_CR20","doi-asserted-by":"publisher","first-page":"eabm6247","DOI":"10.1126\/sciadv.abm6247","volume":"8","author":"VJC Bayley","year":"2022","unstructured":"Bayley VJC, Hadley CC, Harmanci AO, Harmanci AS, Klisch TJ, Patel AJ. Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies. Sci Adv. 2022;8(5):eabm6247. https:\/\/doi.org\/10.1126\/sciadv.abm6247.","journal-title":"Sci Adv"},{"issue":"5","key":"4393_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D, Sturm D, Wirsching HG, Berghoff AS, Baumgarten P, Kratz A, Huang K, Wefers AK, Hovestadt V, Sill M, Ellis HP, Kurian KM, Okuducu AF, Jungk C, Drueschler K, Schick M, Bewerunge-Hudler M, Mawrin C, Seiz-Rosenhagen M, Ketter R, Simon M, Westphal M, Lamszus K, Becker A, Koch A, Schittenhelm J, Rushing EJ, Collins VP, Brehmer S, Chavez L, Platten M, H\u00e4nggi D, Unterberg A, Paulus W, Wick W, Pfister SM, Mittelbronn M, Preusser M, Herold-Mende C, Weller M, von Deimling A. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18(5):682\u201394. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9.","journal-title":"Lancet Oncol"},{"issue":"5","key":"4393_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K, Lucas CG, Casey-Clyde TJ, Vasudevan HN, Liu SJ, Villanueva-Meyer JE, Lam TC, Pu JK, Li LF, Leung GK, Swaney DL, Zhang MY, Chan JW, Qiu Z, Martin MV, Susko MS, Braunstein SE, Bush NAO, Schulte JD, Butowski N, Sneed PK, Berger MS, Krogan NJ, Perry A, Phillips JJ, Solomon DA, Costello JF, McDermott MW, Rich JN, Raleigh DR. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet. 2022;54(5):649\u201359. https:\/\/doi.org\/10.1038\/s41588-022-01061-8.","journal-title":"Nat Genet"},{"issue":"34","key":"4393_CR23","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","volume":"39","author":"SLN Maas","year":"2021","unstructured":"Maas SLN, Stichel D, Hielscher T, Sievers P, Berghoff AS, Schrimpf D, Sill M, Euskirchen P, Blume C, Patel A, Dogan H, Reuss D, Dohmen H, Stein M, Reinhardt A, Suwala AK, Wefers AK, Baumgarten P, Ricklefs F, Rushing EJ, Bewerunge-Hudler M, Ketter R, Schittenhelm J, Jaunmuktane Z, Leu S, Greenway FEA, Bridges LR, Jones T, Grady C, Serrano J, Golfinos J, Sen C, Mawrin C, Jungk C, H\u00e4nggi D, Westphal M, Lamszus K, Etminan N, Jungwirth G, Herold-Mende C, Unterberg A, Harter PN, Wirsching HG, Neidert MC, Ratliff M, Platten M, Snuderl M, Aldape KD, Brandner S, Hench J, Frank S, Pfister SM, Jones DTW, Reifenberger G, Acker T, Wick W, Weller M, Preusser M, von Deimling A, Sahm F; for the German Consortium on Aggressive Meningiomas (KAM). Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated. J Clin Oncol. 2021;39(34):3839\u201352. https:\/\/doi.org\/10.1200\/JCO.21.00784.","journal-title":"J Clin Oncol"},{"issue":"16","key":"4393_CR24","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1097\/CM9.0000000000002391","volume":"135","author":"J Deng","year":"2022","unstructured":"Deng J, Hua L, Bian L, Chen H, Chen L, Cheng H, Dou C, Geng D, Hong T, Ji H, Jiang Y, Lan Q, Li G, Liu Z, Qi S, Qu Y, Shi S, Sun X, Wang H, You Y, Yu H, Yue S, Zhang J, Zhang X, Wang S, Mao Y, Zhong P, Gong Y; Group of Neuro-Oncology, Society of Neurosurgery, Chinese Medical Association. Molecular diagnosis and treatment of meningiomas: an expert consensus (2022). Chin Med J (Engl). 2022;135(16):1894\u2013912. https:\/\/doi.org\/10.1097\/CM9.0000000000002391.","journal-title":"Chin Med J (Engl)"},{"key":"4393_CR25","doi-asserted-by":"publisher","first-page":"910199","DOI":"10.3389\/fonc.2022.910199","volume":"12","author":"EJ Wang","year":"2023","unstructured":"Wang EJ, Haddad AF, Young JS, Morshed RA, Wu JPH, Salha DM, Butowski N, Aghi MK. Recent advances in the molecular prognostication of meningiomas. Front Oncol. 2023;12:910199. https:\/\/doi.org\/10.3389\/fonc.2022.910199.","journal-title":"Front Oncol"},{"issue":"2","key":"4393_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ijc.20733","volume":"114","author":"G Wrobel","year":"2005","unstructured":"Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer. 2005;114(2):249\u201356. https:\/\/doi.org\/10.1002\/ijc.20733.","journal-title":"Int J Cancer"},{"issue":"2\u20133","key":"4393_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/pmic.201400328","volume":"15","author":"S Sharma","year":"2015","unstructured":"Sharma S, Ray S, Mukherjee S, Moiyadi A, Sridhar E, Srivastava S. Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics. 2015;15(2\u20133):394\u2013407. https:\/\/doi.org\/10.1002\/pmic.201400328.","journal-title":"Proteomics"},{"issue":"5","key":"4393_CR28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/biology12050729","volume":"12","author":"L Manfreda","year":"2023","unstructured":"Manfreda L, Rampazzo E, Persano L. Wnt Signaling in Brain Tumors: A Challenging Therapeutic Target. Biology (Basel). 2023;12(5):729. https:\/\/doi.org\/10.3390\/biology12050729.","journal-title":"Biology (Basel)"},{"key":"4393_CR29","doi-asserted-by":"publisher","unstructured":"Papaioannou M-D, Djuric U, Kao J, Karimi S, Zadeh G, Aldape K, Diamandis P. Proteomic analysis of meningiomas reveals clinically distinct molecular patterns, Neuro-Oncology, 2019;21(8):1028\u201338, https:\/\/doi.org\/10.1093\/neuonc\/noz084","DOI":"10.1093\/neuonc\/noz084"},{"issue":"1","key":"4393_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, Dong Q, Wei X. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17(1):46. https:\/\/doi.org\/10.1186\/s13045-024-01563-4.","journal-title":"J Hematol Oncol"},{"key":"4393_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","volume":"10","author":"C Xue","year":"2025","unstructured":"Xue C, Chu Q, Shi Q, et al. Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. Signal Transduct Target Ther. 2025;10:106. https:\/\/doi.org\/10.1038\/s41392-025-02142-w.","journal-title":"Signal Transduct Target Therapy"},{"issue":"5","key":"4393_CR32","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1096\/fj.201700897R","volume":"32","author":"Z Yue","year":"2018","unstructured":"Yue Z, Yuan Z, Zeng L, Wang Y, Lai L, Li J, Sun P, Xue X, Qi J, Yang Z, Zheng Y, Fang Y, Li D, Siwko S, Li Y, Luo J, Liu M. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells. FASEB J. 2018;32(5):2422\u201337. https:\/\/doi.org\/10.1096\/fj.201700897R.","journal-title":"FASEB J"},{"key":"4393_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40364-021-00323-7","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhao T, Zhang S, et al. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy. Biomark Res. 2021;9:68. https:\/\/doi.org\/10.1186\/s40364-021-00323-7.","journal-title":"Biomark Res"},{"key":"4393_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012;123:465\u201372. https:\/\/doi.org\/10.1007\/s00401-011-0922-z.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"4393_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","volume":"123","author":"M Kool","year":"2012","unstructured":"Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, Clifford SC, Pietsch T, von Bueren AO, Rutkowski S, McCabe M, Collins VP, B\u00e4cklund ML, Haberler C, Bourdeaut F, Delattre O, Doz F, Ellison DW, Gilbertson RJ, Pomeroy SL, Taylor MD, Lichter P, Pfister SM. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012;123(4):473\u201384. https:\/\/doi.org\/10.1007\/s00401-012-0958-8.","journal-title":"Acta Neuropathol"},{"key":"4393_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.18632\/oncotarget.28360","volume":"14","author":"S Mani","year":"2023","unstructured":"Mani S, Chatterjee A, Dasgupta A, Shirsat N, Epari S, Chinnaswamy G, Gupta T. WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Oncotarget. 2023;14:105\u201310. https:\/\/doi.org\/10.18632\/oncotarget.28360.","journal-title":"Oncotarget"},{"issue":"6","key":"4393_CR37","doi-asserted-by":"publisher","first-page":"189186","DOI":"10.1016\/j.bbcan.2024.189186","volume":"1879","author":"Y Hou","year":"2024","unstructured":"Hou Y, Zhao Z, Li P, Cao Y, Zhang Y, Guo C, Nie X, Hou J. Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment. Biochim Biophys Acta Rev Cancer. 2024;1879(6):189186. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189186.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"4393_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/cells14030178","volume":"14","author":"A Nayak","year":"2025","unstructured":"Nayak A, Streiff H, Gonzalez I, Adekoya OO, Silva I, Shenoy AK. Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications. Cells. 2025;14(3):178. https:\/\/doi.org\/10.3390\/cells14030178.","journal-title":"Cells"},{"issue":"1","key":"4393_CR39","doi-asserted-by":"publisher","first-page":"vdz055","DOI":"10.1093\/noajnl\/vdz055","volume":"2","author":"J Deng","year":"2020","unstructured":"Deng J, Hua L, Han T, Tian M, Wang D, Tang H, Sun S, Chen H, Cheng H, Zhang T, Xie Q, Wan L, Zhu H, Gong Y. The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations. Neurooncol Adv. 2020;2(1):vdz055. https:\/\/doi.org\/10.1093\/noajnl\/vdz055.","journal-title":"Neurooncol Adv"},{"issue":"1","key":"4393_CR40","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.1038\/s41467-024-52284-8","volume":"15","author":"CD Eaton","year":"2024","unstructured":"Eaton CD, Avalos L, Liu SJ, Chen Z, Zakimi N, Casey-Clyde T, Bisignano P, Lucas CG, Stevenson E, Choudhury A, Vasudevan HN, Magill ST, Young JS, Krogan NJ, Villanueva-Meyer JE, Swaney DL, Raleigh DR. MerlinS13 phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging features. Nat Commun. 2024;15(1):7873. https:\/\/doi.org\/10.1038\/s41467-024-52284-8.","journal-title":"Nat Commun"},{"key":"4393_CR41","doi-asserted-by":"publisher","first-page":"w20129","DOI":"10.4414\/smw.2019.20129","volume":"149","author":"HV Shaw","year":"2019","unstructured":"Shaw HV, Koval A, Katanaev VL. Targeting the Wnt signalling pathway in cancer: prospects and perils. Swiss Med Wkly. 2019;149:w20129. https:\/\/doi.org\/10.4414\/smw.2019.20129.","journal-title":"Swiss Med Wkly"},{"issue":"7","key":"4393_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/cancers8070067","volume":"8","author":"N Pe\u0107ina-\u0160laus","year":"2016","unstructured":"Pe\u0107ina-\u0160laus N, Kafka A, Lechpammer M. Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling. Cancers (Basel). 2016;8(7):67. https:\/\/doi.org\/10.3390\/cancers8070067.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"4393_CR43","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/cdd.2016.54","volume":"23","author":"M Kim","year":"2016","unstructured":"Kim M, Kim S, Lee SH, Kim W, Sohn MJ, Kim HS, Kim J, Jho EH. Merlin inhibits Wnt\/\u03b2-catenin signaling by blocking LRP6 phosphorylation. Cell Death Differ. 2016;23(10):1638\u201347. https:\/\/doi.org\/10.1038\/cdd.2016.54.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4393_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12964-020-00544-7","volume":"18","author":"M Mota","year":"2020","unstructured":"Mota M, Shevde LA. Merlin regulates signaling events at the nexus of development and cancer. Cell Commun Signal. 2020;18(1):63. https:\/\/doi.org\/10.1186\/s12964-020-00544-7.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"4393_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/cancers17010064","volume":"17","author":"SH Nouri","year":"2025","unstructured":"Nouri SH, Nitturi V, Ledbetter E, English CW, Lau S, Klisch TJ, Patel AJ. Role of NF2 Mutation in the Development of Eleven Different Cancers. Cancers (Basel). 2025;17(1):64. https:\/\/doi.org\/10.3390\/cancers17010064.","journal-title":"Cancers (Basel)"},{"issue":"13","key":"4393_CR46","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","volume":"22","author":"HN Vasudevan","year":"2018","unstructured":"Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, Perry A, Raleigh DR. Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation. Cell Rep. 2018;22(13):3672\u201383. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.013.","journal-title":"Cell Rep"},{"issue":"2","key":"4393_CR47","doi-asserted-by":"publisher","first-page":"e70048","DOI":"10.1111\/bpa.70048","volume":"36","author":"Y Shiraki","year":"2026","unstructured":"Shiraki Y, Kurauchi T, Hara A, Esaki N, Mii S, Ando R, et al. Meflin\/ISLR is a meningeal cell-specific marker involved in the development of meninges and meningioma progression. Brain Pathol. 2026;36(2):e70048. https:\/\/doi.org\/10.1111\/bpa.70048.","journal-title":"Brain Pathol"},{"issue":"11","key":"4393_CR48","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.21873\/anticanres.17863","volume":"45","author":"A Kumaria","year":"2025","unstructured":"Kumaria A, Weir P, Goldspring R, Scott I, Leggate A. Osteosclerosis and Meningioma: Implicating the Tumor Suppressor Gene AMER1\/WTX. Anticancer Res. 2025;45(11):5233\u20137. https:\/\/doi.org\/10.21873\/anticanres.17863.","journal-title":"Anticancer Res"},{"issue":"10","key":"4393_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.5483\/bmbrep.2014.47.10.177","volume":"47","author":"M Kim","year":"2014","unstructured":"Kim M, Jho EH. Cross-talk between Wnt\/\u03b2-catenin and Hippo signaling pathways: a brief review. BMB Rep. 2014;47(10):540\u20135. https:\/\/doi.org\/10.5483\/bmbrep.2014.47.10.177.","journal-title":"BMB Rep"},{"key":"4393_CR50","doi-asserted-by":"publisher","first-page":"110350","DOI":"10.1016\/j.cellsig.2022.110350","volume":"95","author":"S Daisy Precilla","year":"2022","unstructured":"Daisy Precilla S, Biswas I, Kuduvalli SS, Anitha TS. Crosstalk between PI3K\/AKT\/mTOR and Wnt\/\u03b2-Catenin signaling in GBM - Could combination therapy checkmate the collusion? Cell Signal. 2022;95:110350. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110350.","journal-title":"Cell Signal"},{"issue":"2","key":"4393_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11060-022-04197-z","volume":"161","author":"V Vasan","year":"2023","unstructured":"Vasan V, Dullea JT, Devarajan A, Ali M, Rutland JW, Gill CM, Kinoshita Y, McBride RB, Gliedman P, Bederson J, Donovan M, Sebra R, Umphlett M, Shrivastava RK. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas. J Neurooncol. 2023;161(2):309\u201316. https:\/\/doi.org\/10.1007\/s11060-022-04197-z.","journal-title":"J Neurooncol"},{"issue":"6","key":"4393_CR52","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/jnci\/djaf022","volume":"117","author":"B Patel","year":"2025","unstructured":"Patel B, Pugazenthi S, English CW, Nitturi V, Pari SS, Mahlokozera T, Leidig WA, Lu HC, Yang A, Roberts K, DeSouza P, McGeehan KP, Mao DD, Sinha N, Ippolito JE, Dahiya S, Petti A, Yano H, Klisch TJ, Harmanci AS, Patel AJ, Kim AH. NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas. J Natl Cancer Inst. 2025;117(6):1175\u201387. https:\/\/doi.org\/10.1093\/jnci\/djaf022.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4393_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1159\/000491774","volume":"48","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Tao L, Yi J, Song H, Chen L. The Role of Canonical Wnt Signaling in Regulating Radioresistance. Cell Physiol Biochem. 2018;48(2):419\u201332. https:\/\/doi.org\/10.1159\/000491774.","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"4393_CR54","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.18632\/oncotarget.3692","volume":"6","author":"HY Chiou","year":"2015","unstructured":"Chiou HY, Lai WK, Huang LC, Huang SM, Chueh SH, Ma HI, Hueng DY. Valproic acid promotes radiosensitization in meningioma stem-like cells. Oncotarget. 2015;6(12):9959\u201369. https:\/\/doi.org\/10.18632\/oncotarget.3692.","journal-title":"Oncotarget"},{"issue":"11","key":"4393_CR55","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/stem.1219","volume":"30","author":"BG Debeb","year":"2012","unstructured":"Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through Wnt\/\u03b2-catenin signaling. Stem Cells. 2012;30(11):2366\u201377. https:\/\/doi.org\/10.1002\/stem.1219.","journal-title":"Stem Cells"},{"issue":"2","key":"4393_CR56","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","volume":"159","author":"J Bostr\u00f6m","year":"2001","unstructured":"Bostr\u00f6m J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G. Alterations of the tumor suppressor genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in atypical and anaplastic meningiomas. Am J Pathol. 2001;159(2):661\u20139. https:\/\/doi.org\/10.1016\/S0002-9440(10)61737-3.","journal-title":"Am J Pathol"},{"issue":"2","key":"4393_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bpa.12110","volume":"24","author":"S Goutagny","year":"2014","unstructured":"Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M. High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol. 2014;24(2):184\u20139. https:\/\/doi.org\/10.1111\/bpa.12110.","journal-title":"Brain Pathol"},{"issue":"1","key":"4393_CR58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/bpa.12892","volume":"31","author":"AD Maier","year":"2021","unstructured":"Maier AD, Stenman A, Svahn F, Mirian C, Bartek J Jr, Juhler M, Zedenius J, Broholm H, Mathiesen T. TERT promoter mutations in primary and secondary WHO grade III meningioma. Brain Pathol. 2021;31(1):61\u20139. https:\/\/doi.org\/10.1111\/bpa.12892.","journal-title":"Brain Pathol"},{"issue":"1","key":"4393_CR59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s40478-023-01690-y","volume":"11","author":"J Wach","year":"2023","unstructured":"Wach J, Basaran AE, Arlt F, Vychopen M, Seidel C, Barrantes-Freer A, M\u00fcller W, Gaunitz F, G\u00fcresir E. CDKN2A\/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data. Acta Neuropathol Commun. 2023;11(1):189. https:\/\/doi.org\/10.1186\/s40478-023-01690-y.","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"4393_CR60","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/neuonc\/noae170","volume":"27","author":"F Sahm","year":"2025","unstructured":"Sahm F, Aldape KD, Brastianos PK, Brat DJ, Dahiya S, von Deimling A, Giannini C, Gilbert MR, Louis DN, Raleigh DR, Reifenberger G, Santagata S, Sarkar C, Zadeh G, Wesseling P, Perry A. cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Neuro Oncol. 2025;27(2):319\u201330. https:\/\/doi.org\/10.1093\/neuonc\/noae170.","journal-title":"Neuro Oncol"},{"issue":"10","key":"4393_CR61","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","volume":"26","author":"JZ Wang","year":"2024","unstructured":"Wang JZ, Landry AP, Raleigh DR, Sahm F, Walsh KM, Goldbrunner R, Yefet LS, Tonn JC, Gui C, Ostrom QT, Barnholtz-Sloan J, Perry A, Ellenbogen Y, Hanemann CO, Jungwirth G, Jenkinson MD, Tabatabai G, Mathiesen TI, McDermott MW, Tatagiba M, la Foug\u00e8re C, Maas SLN, Galldiks N, Albert NL, Brastianos PK, Ehret F, Minniti G, Lamszus K, Ricklefs FL, Schittenhelm J, Drummond KJ, Dunn IF, Pathmanaban ON, Cohen-Gadol AA, Sulman EP, Tabouret E, Le Rhun E, Mawrin C, Moliterno J, Weller M, Bi WL, Gao A, Yip S, Niyazi M; International Consortium on Meningiomas (ICOM); Aldape K, Wen PY, Short S, Preusser M, Nassiri F, Zadeh G. Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol. 2024;26(10):1742\u201380. https:\/\/doi.org\/10.1093\/neuonc\/noae082. International Consortium on Meningiomas (ICOM).","journal-title":"Neuro Oncol"},{"key":"4393_CR62","doi-asserted-by":"publisher","first-page":"1182759","DOI":"10.3389\/fnmol.2023.1182759","volume":"16","author":"Z Li","year":"2023","unstructured":"Li Z, Gao Y, Zhang J, Han L, Zhao H. DNA methylation meningioma biomarkers: attributes and limitations. Front Mol Neurosci. 2023;16:1182759. https:\/\/doi.org\/10.3389\/fnmol.2023.1182759.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"4393_CR63","doi-asserted-by":"publisher","first-page":"e13046","DOI":"10.1111\/bpa.13046","volume":"32","author":"C Mawrin","year":"2022","unstructured":"Mawrin C, Koch R, Waldt N, Sandalcioglu IE, Braunsdorf WEK, Warnke JP, Goehre F, Meisel HJ, Ewald C, Neyazi S, Sch\u00fcller U, Kirches E. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas. Brain Pathol. 2022;32(2):e13046. https:\/\/doi.org\/10.1111\/bpa.13046.","journal-title":"Brain Pathol"},{"issue":"12","key":"4393_CR64","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1593\/neo.111060","volume":"13","author":"L Zhou","year":"2011","unstructured":"Zhou L, Ercolano E, Ammoun S, Schmid MC, Barczyk MA, Hanemann CO. Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt\/\u03b2-catenin signaling linked to the PDGFR\/Src and Rac\/PAK pathways. Neoplasia. 2011;13(12):1101\u201312. https:\/\/doi.org\/10.1593\/neo.111060.","journal-title":"Neoplasia"},{"issue":"5","key":"4393_CR65","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2015.125","volume":"35","author":"AM Petrilli","year":"2016","unstructured":"Petrilli AM, Fern\u00e1ndez-Valle C. Role of Merlin\/NF2 inactivation in tumor biology. Oncogene. 2016;35(5):537\u201348. https:\/\/doi.org\/10.1038\/onc.2015.125.","journal-title":"Oncogene"},{"issue":"17","key":"4393_CR66","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/onc.2010.20","volume":"29","author":"EE Bosco","year":"2010","unstructured":"Bosco EE, Nakai Y, Hennigan RF, Ratner N, Zheng Y. NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation. Oncogene. 2010;29(17):2540\u20139. https:\/\/doi.org\/10.1038\/onc.2010.20.","journal-title":"Oncogene"},{"issue":"10","key":"4393_CR67","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/14737175.2025.2548327","volume":"25","author":"S Quach","year":"2025","unstructured":"Quach S, Simon M. Diagnostic advances and challenges in meningioma. Expert Rev Neurother. 2025;25(10):1209\u201321. https:\/\/doi.org\/10.1080\/14737175.2025.2548327.","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"4393_CR68","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/cancers15112945","volume":"15","author":"E Marastoni","year":"2023","unstructured":"Marastoni E, Barresi V. Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical Outcome. Cancers (Basel). 2023;15(11):2945. https:\/\/doi.org\/10.3390\/cancers15112945.","journal-title":"Cancers (Basel)"},{"key":"4393_CR69","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","volume":"133","author":"A Olar","year":"2017","unstructured":"Olar A, Wani KM, Wilson CD, et al. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol. 2017;133:431\u201344. https:\/\/doi.org\/10.1007\/s00401-017-1678-x.","journal-title":"Acta Neuropathol"},{"issue":"7874","key":"4393_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, Macklin AM, Khan S, Singh O, Karimi S, Corona RI, Liu LY, Chen CY, Chakravarthy A, Wei Q, Mehani B, Suppiah S, Gao A, Workewych AM, Tabatabai G, Boutros PC, Bader GD, de Carvalho DD, Kislinger T, Aldape K, Zadeh G. A clinically applicable integrative molecular classification of meningiomas. Nature. 2021;597(7874):119\u201325. https:\/\/doi.org\/10.1038\/s41586-021-03850-3.","journal-title":"Nature"},{"issue":"3","key":"4393_CR71","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ncrna.2024.02.011","volume":"9","author":"O Beylerli","year":"2024","unstructured":"Beylerli O, Ilyasova T, Shi H, Sufianov A. MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets. Noncoding RNA Res. 2024;9(3):641\u20138. https:\/\/doi.org\/10.1016\/j.ncrna.2024.02.011.","journal-title":"Noncoding RNA Res"},{"issue":"5","key":"4393_CR72","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/gtmb.2011.0245","volume":"16","author":"F Aydemir","year":"2012","unstructured":"Aydemir F, Yurtcu E, Balci TB, Sahin FI, Gulsen S, Altinors N. Identification of promoter region methylation patterns of MGMT, CDKN2A, GSTP1, and THBS1 genes in intracranial meningioma patients. Genet Test Mol Biomarkers. 2012;16(5):335\u201340. https:\/\/doi.org\/10.1089\/gtmb.2011.0245.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"6","key":"4393_CR73","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/modpathol.3800111","volume":"17","author":"VJ Amatya","year":"2004","unstructured":"Amatya VJ, Takeshima Y, Inai K. Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation. Mod Pathol. 2004;17(6):705\u201310. https:\/\/doi.org\/10.1038\/modpathol.3800111.","journal-title":"Mod Pathol"},{"issue":"3","key":"4393_CR74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13353-013-0149-x","volume":"54","author":"A Majchrzak-Celi\u0144ska","year":"2013","unstructured":"Majchrzak-Celi\u0144ska A, Paluszczak J, Kleszcz R, Magiera M, Barciszewska AM, Nowak S, Baer-Dubowska W. Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients. J Appl Genet. 2013;54(3):335\u201344. https:\/\/doi.org\/10.1007\/s13353-013-0149-x.","journal-title":"J Appl Genet"},{"issue":"9","key":"4393_CR75","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00432-015-1930-5","volume":"141","author":"A Majchrzak-Celi\u0144ska","year":"2015","unstructured":"Majchrzak-Celi\u0144ska A, Paluszczak J, Szalata M, Barciszewska AM, Nowak S, Baer-Dubowska W. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade. J Cancer Res Clin Oncol. 2015;141(9):1593\u2013601. https:\/\/doi.org\/10.1007\/s00432-015-1930-5.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"4393_CR76","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.trsl.2012.05.007","volume":"160","author":"A Di Vinci","year":"2012","unstructured":"Di Vinci A, Brigati C, Casciano I, Banelli B, Borz\u00ec L, Forlani A, Ravetti GL, Allemanni G, Melloni I, Zona G, Spaziante R, Merlo DF, Romani M. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas. Transl Res. 2012;160(5):355\u201362. https:\/\/doi.org\/10.1016\/j.trsl.2012.05.007.","journal-title":"Transl Res"},{"issue":"4","key":"4393_CR77","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3171\/2013.7.JNS13311","volume":"119","author":"J Vengoechea","year":"2013","unstructured":"Vengoechea J, Sloan AE, Chen Y, Guan X, Ostrom QT, Kerstetter A, Capella D, Cohen ML, Wolinsky Y, Devine K, Selman W, Barnett GH, Warnick RE, McPherson C, Chiocca EA, Elder JB, Barnholtz-Sloan JS. Methylation markers of malignant potential in meningiomas. J Neurosurg. 2013;119(4):899\u2013906. https:\/\/doi.org\/10.3171\/2013.7.JNS13311.","journal-title":"J Neurosurg"},{"issue":"3","key":"4393_CR78","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11060-010-0411-6","volume":"103","author":"JA Kandenwein","year":"2011","unstructured":"Kandenwein JA, Park-Simon TW, Schramm J, Simon M. uPA\/PAI-1 expression and uPA promoter methylation in meningiomas. J Neurooncol. 2011;103(3):533\u20139. https:\/\/doi.org\/10.1007\/s11060-010-0411-6.","journal-title":"J Neurooncol"},{"issue":"4","key":"4393_CR79","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.4238\/2012.August.17.7","volume":"11","author":"MN Chen","year":"2012","unstructured":"Chen MN, Wang P, Zhang J, Zhou BY, Mao Q, Liu YH. Analysis of the role of hMLH1 hypermethylation and microsatellite instability in meningioma progression. Genet Mol Res. 2012;11(4):3933\u201341. PMID: 22930430.","journal-title":"Genet Mol Res"},{"issue":"2","key":"4393_CR80","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3171\/JNS-07\/08\/0398","volume":"107","author":"Y Nakane","year":"2007","unstructured":"Nakane Y, Natsume A, Wakabayashi T, Oi S, Ito M, Inao S, Saito K, Yoshida J. Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A. J Neurosurg. 2007;107(2):398\u2013404. https:\/\/doi.org\/10.3171\/JNS-07\/08\/0398.","journal-title":"J Neurosurg"},{"key":"4393_CR81","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-016-2226-6","volume":"130","author":"G F\u00fcrtjes","year":"2016","unstructured":"F\u00fcrtjes G, K\u00f6chling M, Peetz-Dienhart S, et al. hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas. J Neurooncol. 2016;130:79\u201387. https:\/\/doi.org\/10.1007\/s11060-016-2226-6.","journal-title":"J Neurooncol"},{"key":"4393_CR82","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10143-019-01087-3","volume":"43","author":"L St\u00f6gbauer","year":"2020","unstructured":"St\u00f6gbauer L, Stummer W, Senner V, et al. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas \u2013 a systematic review. Neurosurg Rev. 2020;43:903\u201310. https:\/\/doi.org\/10.1007\/s10143-019-01087-3.","journal-title":"Neurosurg Rev"},{"key":"4393_CR83","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00401-004-0911-6","volume":"108","author":"MJ Bello","year":"2004","unstructured":"Bello MJ, Ami\u00f1oso C, Lopez-Marin I, et al. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol. 2004;108:413\u201321. https:\/\/doi.org\/10.1007\/s00401-004-0911-6.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"4393_CR84","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1750-3639.2009.00340.x","volume":"20","author":"D Barski","year":"2010","unstructured":"Barski D, Wolter M, Reifenberger G, Riemenschneider MJ. Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathol. 2010;20(3):623\u201331. https:\/\/doi.org\/10.1111\/j.1750-3639.2009.00340.x.","journal-title":"Brain Pathol"},{"issue":"4","key":"4393_CR85","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1215\/15228517-2008-096","volume":"11","author":"P Jun","year":"2009","unstructured":"Jun P, Hong C, Lal A, Wong JM, McDermott MW, Bollen AW, Plass C, Held WA, Smiraglia DJ, Costello JF. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Neuro Oncol. 2009;11(4):414\u201322. https:\/\/doi.org\/10.1215\/15228517-2008-096.","journal-title":"Neuro Oncol"},{"issue":"8","key":"4393_CR86","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/neuonc\/noab036","volume":"23","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N, Pirouzmand N, Ng HK, Saladino A, Pollo B, Dimeco F, Yip S, Gao A, Aldape KD, Zadeh G; International Consortium on Meningiomas. Loss of H3K27me3 in meningiomas. Neuro Oncol. 2021;23(8):1282\u201391. https:\/\/doi.org\/10.1093\/neuonc\/noab036.","journal-title":"Neuro Oncol"},{"key":"4393_CR87","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s40478-023-01615-9","volume":"11","author":"G Cello","year":"2023","unstructured":"Cello G, Patel RV, McMahon JT, et al. Impact of H3K27 trimethylation loss in meningiomas: a meta-analysis. Acta Neuropathol Commun. 2023;11:122. https:\/\/doi.org\/10.1186\/s40478-023-01615-9.","journal-title":"acta neuropathol commun"},{"issue":"8","key":"4393_CR88","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3346\/jkms.2015.30.8.1157","volume":"30","author":"SH Lee","year":"2015","unstructured":"Lee SH, Lee EH, Lee SH, Lee YM, Kim HD, Kim YZ. Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical Meningioma. J Korean Med Sci. 2015;30(8):1157\u201366. https:\/\/doi.org\/10.3346\/jkms.2015.30.8.1157.","journal-title":"J Korean Med Sci"},{"issue":"8","key":"4393_CR89","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jcmm.17709","volume":"27","author":"Z Li","year":"2023","unstructured":"Li Z, Zhao J, Tang Y. Advances in the role of SWI\/SNF complexes in tumours. J Cell Mol Med. 2023;27(8):1023\u201331. https:\/\/doi.org\/10.1111\/jcmm.17709.","journal-title":"J Cell Mol Med"},{"key":"4393_CR90","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clineuro.2017.03.016","volume":"156","author":"S Katar","year":"2017","unstructured":"Katar S, Baran O, Evran S, Cevik S, Akkaya E, Baran G, Antar V, Hanimoglu H, Kaynar MY. Expression of miRNA-21, miRNA-107, miRNA-137 and miRNA-29b in meningioma. Clin Neurol Neurosurg. 2017;156:66\u201370. https:\/\/doi.org\/10.1016\/j.clineuro.2017.03.016.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"4393_CR91","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bbrc.2015.03.038","volume":"460","author":"M Wang","year":"2015","unstructured":"Wang M, Deng X, Ying Q, Jin T, Li M, Liang C. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma. Biochem Biophys Res Commun. 2015;460(2):354\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.038.","journal-title":"Biochem Biophys Res Commun"},{"key":"4393_CR92","doi-asserted-by":"publisher","unstructured":"Ludwig N, Kim Y-J, Mueller SC, Backes C, Werner TV, Galata V, Sartorius E, Bohle RM, Keller A, Meese E. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs, Neuro-Oncology, 2015;17(9):1250\u201360, https:\/\/doi.org\/10.1093\/neuonc\/nov014","DOI":"10.1093\/neuonc\/nov014"},{"issue":"39","key":"4393_CR93","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1038\/onc.2012.468","volume":"32","author":"N Kliese","year":"2013","unstructured":"Kliese N, Gobrecht P, Pachow D, Andrae N, Wilisch-Neumann A, Kirches E, Riek-Burchardt M, Angenstein F, Reifenberger G, Riemenschneider MJ, Meese E, Panayotova-Dimitrova D, Gutmann DH, Mawrin C. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene. 2013;32(39):4712\u201320. https:\/\/doi.org\/10.1038\/onc.2012.468.","journal-title":"Oncogene"},{"issue":"1","key":"4393_CR94","doi-asserted-by":"publisher","first-page":"200782","DOI":"10.1016\/j.omton.2024.200782","volume":"32","author":"R Joshi","year":"2024","unstructured":"Joshi R, Sharma A, Kulshreshtha R. Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma. Mol Ther Oncol. 2024;32(1):200782. https:\/\/doi.org\/10.1016\/j.omton.2024.200782.","journal-title":"Mol Ther Oncol"},{"issue":"21","key":"4393_CR95","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1128\/MCB.00332-09","volume":"29","author":"O Saydam","year":"2009","unstructured":"Saydam O, Shen Y, W\u00fcrdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM, Breakefield XO. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt\/beta-catenin signaling pathway. Mol Cell Biol. 2009;29(21):5923\u201340. https:\/\/doi.org\/10.1128\/MCB.00332-09.","journal-title":"Mol Cell Biol"},{"issue":"15","key":"4393_CR96","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1002\/cncr.35279","volume":"130","author":"AL Hsieh","year":"2024","unstructured":"Hsieh AL, Bi WL, Ramesh V, Brastianos PK, Plotkin SR. Evolving concepts in meningioma management in the era of genomics. Cancer. 2024;130(15):2586\u2013600. https:\/\/doi.org\/10.1002\/cncr.35279.","journal-title":"Cancer"},{"issue":"13","key":"4393_CR97","doi-asserted-by":"publisher","first-page":"10671","DOI":"10.18632\/oncotarget.3870","volume":"6","author":"P Domingues","year":"2015","unstructured":"Domingues P, Gonz\u00e1lez-Tablas M, Otero \u00c1, Pascual D, Ruiz L, Miranda D, Sousa P, Gon\u00e7alves JM, Lopes MC, Orfao A,Tabernero MD. Genetic\/molecular alterations of meningiomas and the signaling pathways targeted. Oncotarget. 2015;6(13):10671\u201388. https:\/\/doi.org\/10.18632\/oncotarget.3870.","journal-title":"Oncotarget"},{"key":"4393_CR98","doi-asserted-by":"publisher","first-page":"538845","DOI":"10.3389\/fonc.2020.538845","volume":"10","author":"Z Shao","year":"2020","unstructured":"Shao Z, Liu L, Zheng Y, Tu S, Pan Y, Yan S, Wei Q, Shao A, Zhang J. Molecular Mechanism and Approach in Progression of Meningioma. Front Oncol. 2020;10:538845. https:\/\/doi.org\/10.3389\/fonc.2020.538845.","journal-title":"Front Oncol"},{"key":"4393_CR99","doi-asserted-by":"publisher","unstructured":"Williams EA, Santagata S, Wakimoto H, Shankar GM, Barker FG 2nd, Sharaf R, Reddy A, Spear P, Alexander BM, Ross JS, Brastianos PK, Cahill DP, Ramkissoon SH, Juratli TA. Distinct genomic subclasses of high-grade\/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun. 2020;8(1):171. https:\/\/doi.org\/10.1186\/s40478-020-01040-2.","DOI":"10.1186\/s40478-020-01040-2"},{"issue":"6","key":"4393_CR100","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/his.15539","volume":"87","author":"M Kashiwagi-Hakozaki","year":"2025","unstructured":"Kashiwagi-Hakozaki M, Ikemura M, Miyawaki S, Teranishi Y, Okano A, Saito N, Ushiku T. Merlin immunohistochemistry is a reliable surrogate marker for NF2 gene alterations in meningioma. Histopathology. 2025;87(6):915\u201322. https:\/\/doi.org\/10.1111\/his.15539.","journal-title":"Histopathology"},{"issue":"14","key":"4393_CR101","doi-asserted-by":"publisher","first-page":"17991","DOI":"10.18632\/oncotarget.7494","volume":"7","author":"KA Morrow","year":"2016","unstructured":"Morrow KA, Das S, Meng E, Menezes ME, Bailey SK, Metge BJ, Buchsbaum DJ, Samant RS, Shevde LA. Loss of tumor suppressor Merlin results in aberrant activation of Wnt\/\u03b2-catenin signaling in cancer. Oncotarget. 2016;7(14):17991\u20138005. https:\/\/doi.org\/10.18632\/oncotarget.7494.","journal-title":"Oncotarget"},{"key":"4393_CR102","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12885-023-10624-9","volume":"23","author":"SA Cain","year":"2023","unstructured":"Cain SA, Pope B, Mangiola S, et al. Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression. BMC Cancer. 2023;23:216. https:\/\/doi.org\/10.1186\/s12885-023-10624-9.","journal-title":"BMC Cancer"},{"issue":"15","key":"4393_CR103","doi-asserted-by":"publisher","first-page":"8542","DOI":"10.3390\/ijms25158542","volume":"25","author":"V Boccardi","year":"2024","unstructured":"Boccardi V, Marano L, Aging. Cancer, and Inflammation: The Telomerase Connection. Int J Mol Sci. 2024;25(15):8542. https:\/\/doi.org\/10.3390\/ijms25158542.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4393_CR104","doi-asserted-by":"publisher","first-page":"djv377","DOI":"10.1093\/jnci\/djv377","volume":"108","author":"F Sahm","year":"2016","unstructured":"Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T, Wang Q, Sulman EP, Adeberg S, Koch A, Okuducu AF, Brehmer S, Schittenhelm J, Becker A, Brokinkel B, Schmidt M, Ull T, Gousias K, Kessler AF, Lamszus K, Debus J, Mawrin C, Kim YJ, Simon M, Ketter R, Paulus W, Aldape KD, Herold-Mende C, von Deimling A. TERT Promoter Mutations and Risk of Recurrence in Meningioma. J Natl Cancer Inst. 2016;108(5):djv377. https:\/\/doi.org\/10.1093\/jnci\/djv377.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"4393_CR105","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/diagnostics11091624","volume":"11","author":"M Mellai","year":"2021","unstructured":"Mellai M, Porrini Prandini O, Mustaccia A, Fogazzi V, Allesina M, Krengli M, Boldorini R. Human TERT Promoter Mutations in Atypical and Anaplastic Meningiomas. Diagnostics (Basel). 2021;11(9):1624. https:\/\/doi.org\/10.3390\/diagnostics11091624.","journal-title":"Diagnostics (Basel)"},{"issue":"12","key":"4393_CR106","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/neuonc\/noy104","volume":"20","author":"S Spiegl-Kreinecker","year":"2018","unstructured":"Spiegl-Kreinecker S, L\u00f6tsch D, Neumayer K, Kastler L, Gojo J, Pirker C, Pichler J, Weis S, Kumar R, Webersinke G, Gruber A, Berger W. TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro Oncol. 2018;20(12):1584\u201393. https:\/\/doi.org\/10.1093\/neuonc\/noy104.","journal-title":"Neuro Oncol"},{"issue":"16","key":"4393_CR107","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.3390\/cancers13164202","volume":"13","author":"S Kotiyal","year":"2021","unstructured":"Kotiyal S, Evason KJ. Exploring the Interplay of Telomerase Reverse Transcriptase and \u03b2-Catenin in Hepatocellular Carcinoma. Cancers (Basel). 2021;13(16):4202. https:\/\/doi.org\/10.3390\/cancers13164202.","journal-title":"Cancers (Basel)"},{"issue":"41","key":"4393_CR108","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.2174\/1381612820666140630095606","volume":"20","author":"G Saretzki","year":"2014","unstructured":"Saretzki G. Extra-telomeric functions of human telomerase: cancer, mitochondria and oxidative stress. Curr Pharm Design. 2014;20(41):6386\u2013403. https:\/\/doi.org\/10.2174\/1381612820666140630095606.","journal-title":"Curr Pharm Design"},{"issue":"8","key":"4393_CR109","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/15476286.2015.1134413","volume":"13","author":"JH Teichroeb","year":"2016","unstructured":"Teichroeb JH, Kim J, Betts DH. The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance. RNA Biol. 2016;13(8):707\u201319. https:\/\/doi.org\/10.1080\/15476286.2015.1134413.","journal-title":"RNA Biol"},{"issue":"7","key":"4393_CR110","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/cancers17071165","volume":"17","author":"S Giunco","year":"2025","unstructured":"Giunco S, Petrara MR, Indraccolo S, Ciminale V, De Rossi A. Beyond Telomeres: Unveiling the Extratelomeric Functions of TERT in B-Cell Malignancies. Cancers (Basel). 2025;17(7):1165. https:\/\/doi.org\/10.3390\/cancers17071165.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4393_CR111","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00401-023-02571-3","volume":"146","author":"JZ Wang","year":"2023","unstructured":"Wang JZ, Patil V, Liu J, Dogan H, Tabatabai G, Yefet LS, Behling F, Hoffman E, Bunda S, Yakubov R, Kaloti R, Brandner S, Gao A, Cohen-Gadol A, Barnholtz-Sloan J, Skardelly M, Tatagiba M, Raleigh DR, Sahm F, Boutros PC, Aldape K; International Consortium on Meningiomas (ICOM); Nassiri F, Zadeh G. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. Acta Neuropathol. 2023;146(1):145\u201362. https:\/\/doi.org\/10.1007\/s00401-023-02571-3.","journal-title":"Acta Neuropathol"},{"issue":"17","key":"4393_CR112","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","volume":"17","author":"FJ Stott","year":"1998","unstructured":"Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 1998;17(17):5001\u201314. https:\/\/doi.org\/10.1093\/emboj\/17.17.5001.","journal-title":"EMBO J"},{"issue":"6","key":"4393_CR113","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3390\/ijms22062935","volume":"22","author":"P \u0141ukasik","year":"2021","unstructured":"\u0141ukasik P, Za\u0142uski M, Gutowska I. Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review. Int J Mol Sci. 2021;22(6):2935. https:\/\/doi.org\/10.3390\/ijms22062935.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4393_CR114","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1158\/2159-8290.CD-15-0196","volume":"5","author":"AS McNeal","year":"2015","unstructured":"McNeal AS, Liu K, Nakhate V, Natale CA, Duperret EK, Capell BC, Dentchev T, Berger SL, Herlyn M, Seykora JT, Ridky TW. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma. Cancer Discov. 2015;5(10):1072\u201385. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0196.","journal-title":"Cancer Discov"},{"key":"4393_CR115","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","volume":"8","author":"R Zhao","year":"2016","unstructured":"Zhao R, Choi BY, Lee MH, Bode AM, Dong Z. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer. EBioMedicine. 2016;8:30\u20139. https:\/\/doi.org\/10.1016\/j.ebiom.2016.04.017.","journal-title":"EBioMedicine"},{"issue":"4","key":"4393_CR116","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00401-023-02543-7","volume":"145","author":"AB Khan","year":"2023","unstructured":"Khan AB, English CW, Chen WC, Athukuri P, Bayley VJC, Brandt VL, Shetty A, Hadley CC, Choudhury A, Lu HC, Harmanci AO, Harmanci AS, Magill ST, Raleigh DR, Klisch TJ, Patel AJ. Even heterozygous loss of CDKN2A\/B greatly accelerates recurrence in aggressive meningioma. Acta Neuropathol. 2023;145(4):501\u20133. https:\/\/doi.org\/10.1007\/s00401-023-02543-7.","journal-title":"Acta Neuropathol"},{"key":"4393_CR117","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41467-019-09321-8","volume":"10","author":"P Krimpenfort","year":"2019","unstructured":"Krimpenfort P, Snoek M, Lambooij JP, et al. A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis. Nat Commun. 2019;10:1425. https:\/\/doi.org\/10.1038\/s41467-019-09321-8.","journal-title":"Nat Commun"},{"issue":"12","key":"4393_CR118","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.18632\/aging.205945","volume":"16","author":"X Cheng","year":"2024","unstructured":"Cheng X, Yang F, Li Y, Cao Y, Zhang M, Ji J, Bai Y, Li Q, Yu Q, Gao D. The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer. Aging (Albany NY). 2024;16(12):10512\u201338. https:\/\/doi.org\/10.18632\/aging.205945.","journal-title":"Aging"},{"issue":"11","key":"4393_CR119","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/nox094","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Santagata S. BAP1 mutations in high-grade meningioma: implications for patient care. Neuro Oncol. 2017;19(11):1447\u201356. https:\/\/doi.org\/10.1093\/neuonc\/nox094.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4393_CR120","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00401-020-02161-7","volume":"140","author":"EA Williams","year":"2020","unstructured":"Williams EA, Wakimoto H, Shankar GM, Barker FG 2nd, Brastianos PK, Santagata S, Sokol ES, Pavlick DC, Shah N, Reddy A, Venstrom JM, Alexander BM, Ross JS, Cahill DP, Ramkissoon SH, Juratli TA. Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features. Acta Neuropathol. 2020;140(1):89\u201393. https:\/\/doi.org\/10.1007\/s00401-020-02161-7.","journal-title":"Acta Neuropathol"},{"key":"4393_CR121","doi-asserted-by":"publisher","first-page":"1587752","DOI":"10.3389\/fonc.2025.1587752","volume":"15","author":"E Reusch","year":"2025","unstructured":"Reusch E, Peh KH, Morgan R, Momo H, Orren D, Rock S, Pittman T, Neltner J, Kolesar J, Villano J. Case Report: Advanced grade 2 meningioma with PBRM1 inactivation with prolonged response to immunotherapy. Front Oncol. 2025;15:1587752. https:\/\/doi.org\/10.3389\/fonc.2025.1587752.","journal-title":"Front Oncol"},{"issue":"8","key":"4393_CR122","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1007\/s00432-022-04442-y","volume":"149","author":"D Chaluts","year":"2023","unstructured":"Chaluts D, Dullea JT, Ali M, Vasan V, Devarajan A, Rutland JW, Gill CM, Ellis E, Kinoshita Y, McBride RB, Bederson J, Donovan M, Sebra R, Umphlett M, Shrivastava RK. ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas. J Cancer Res Clin Oncol. 2023;149(8):5165\u201372. https:\/\/doi.org\/10.1007\/s00432-022-04442-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4393_CR123","doi-asserted-by":"publisher","first-page":"754e1","DOI":"10.1016\/j.wneu.2016.10.047","volume":"97","author":"M Bujko","year":"2017","unstructured":"Bujko M, Machnicki MM, Grecka E, Rusetska N, Matyja E, Kober P, Mandat T, Rydzanicz M, P\u0142oski R, Krajewski R, Bonicki W, Stok\u0142osa T, Siedlecki JA. Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype. World Neurosurg. 2017;97:754.e1\u2013754.e6. https:\/\/doi.org\/10.1016\/j.wneu.2016.10.047.","journal-title":"World Neurosurg"},{"issue":"2","key":"4393_CR124","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00401-020-02247-2","volume":"141","author":"P Sievers","year":"2021","unstructured":"Sievers P, Sill M, Blume C, Tauziede-Espariat A, Schrimpf D, Stichel D, Reuss DE, Dogan H, Hartmann C, Mawrin C, Hasselblatt M, Stummer W, Schick U, Hench J, Frank S, Ketter R, Schweizer L, Schittenhelm J, Puget S, Brandner S, Jaunmuktane Z, K\u00fcsters B, Abdullaev Z, Pekmezci M, Snuderl M, Ratliff M, Herold-Mende C, Unterberg A, Aldape K, Ellison DW, Wesseling P, Reifenberger G, Wick W, Perry A, Varlet P, Pfister SM, Jones DTW, von Deimling A, Sahm F, The German Consortium \u201cAggressive Meningiomas\u201d. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1. Acta Neuropathol. 2021;141(2):281\u201390. https:\/\/doi.org\/10.1007\/s00401-020-02247-2.","journal-title":"Acta Neuropathol"},{"key":"4393_CR125","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41588-022-01077-0","volume":"54","author":"R St. Pierre","year":"2022","unstructured":"St. Pierre R, Collings CK, Sam\u00e9 Guerra DD, et al. SMARCE1 deficiency generates a targetable mSWI\/SNF dependency in clear cell meningioma. Nat Genet. 2022;54:861\u201373. https:\/\/doi.org\/10.1038\/s41588-022-01077-0.","journal-title":"Nat Genet"},{"issue":"3","key":"4393_CR126","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajhg.2012.07.015","volume":"91","author":"M Aavikko","year":"2012","unstructured":"Aavikko M, Li SP, Saarinen S, Alhopuro P, Kaasinen E, Morgunova E, Li Y, Vesanen K, Smith MJ, Evans DG, P\u00f6yh\u00f6nen M, Kiuru A, Auvinen A, Aaltonen LA, Taipale J, Vahteristo P. Loss of SUFU function in familial multiple meningioma. Am J Hum Genet. 2012;91(3):520\u20136. https:\/\/doi.org\/10.1016\/j.ajhg.2012.07.015.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4393_CR127","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4132\/jptm.2019.11.05","volume":"54","author":"YS Lee","year":"2020","unstructured":"Lee YS, Lee YS. Molecular characteristics of meningiomas. J Pathol Transl Med. 2020;54(1):45\u201363. https:\/\/doi.org\/10.4132\/jptm.2019.11.05.","journal-title":"J Pathol Transl Med"},{"key":"4393_CR128","doi-asserted-by":"publisher","first-page":"885155","DOI":"10.3389\/fonc.2022.885155","volume":"12","author":"J Kim","year":"2022","unstructured":"Kim J, Hwang K, Kwon HJ, Lee JE, Lee KS, Choe G, Han JH, Kim CY. Clinicopathologic Characteristics of Grade 2\/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing. Front Oncol. 2022;12:885155. https:\/\/doi.org\/10.3389\/fonc.2022.885155.","journal-title":"Front Oncol"},{"issue":"3","key":"4393_CR129","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/biology14030315","volume":"14","author":"N Salut","year":"2025","unstructured":"Salut N, Gamallat Y, Seyedi S, Felipe Lima J, Ghosh S, Bismar TA. Unraveling the Prognostic Significance of BRCA1-Associated Protein 1 (BAP1) Expression in Advanced and Castrate-Resistant Prostate Cancer. Biology (Basel). 2025;14(3):315. https:\/\/doi.org\/10.3390\/biology14030315.","journal-title":"Biology (Basel)"},{"key":"4393_CR130","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.isci.2019.04.027","volume":"15","author":"EG Porter","year":"2019","unstructured":"Porter EG, Dhiman A, Chowdhury B, Carter BC, Lin H, Stewart JC, Kazemian M, Wendt MK, Dykhuizen EC. PBRM1 Regulates Stress Response in Epithelial Cells. iScience. 2019;15:196\u2013210. https:\/\/doi.org\/10.1016\/j.isci.2019.04.027.","journal-title":"iScience"},{"issue":"2","key":"4393_CR131","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3892\/ol.2024.14525","volume":"28","author":"S Aluksanasuwan","year":"2024","unstructured":"Aluksanasuwan S, Somsuan K, Wanna-Udom S, Roytrakul S, Morchang A, Rongjumnong A, Sakulsak N. Proteomic insights into the regulatory function of ARID1A in colon cancer cells. Oncol Lett. 2024;28(2):392. https:\/\/doi.org\/10.3892\/ol.2024.14525.","journal-title":"Oncol Lett"},{"issue":"1","key":"4393_CR132","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ydbio.2011.07.035","volume":"358","author":"TH Min","year":"2011","unstructured":"Min TH, Kriebel M, Hou S, Pera EM. The dual regulator Sufu integrates Hedgehog and Wnt signals in the early Xenopus embryo. Dev Biol. 2011;358(1):262\u201376. https:\/\/doi.org\/10.1016\/j.ydbio.2011.07.035.","journal-title":"Dev Biol"},{"key":"4393_CR133","doi-asserted-by":"publisher","first-page":"858782","DOI":"10.3389\/fonc.2022.858782","volume":"12","author":"K Shah","year":"2022","unstructured":"Shah K, Kazi JU. Phosphorylation-Dependent Regulation of WNT\/Beta-Catenin Signaling. Front Oncol. 2022;12:858782. https:\/\/doi.org\/10.3389\/fonc.2022.858782.","journal-title":"Front Oncol"},{"issue":"2","key":"4393_CR134","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1128\/MCB.00063-09","volume":"30","author":"PM Evans","year":"2010","unstructured":"Evans PM, Chen X, Zhang W, Liu C. KLF4 interacts with beta-catenin\/TCF4 and blocks p300\/CBP recruitment by beta-catenin. Mol Cell Biol. 2010;30(2):372\u201381. https:\/\/doi.org\/10.1128\/MCB.00063-09.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"4393_CR135","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2009.04.059","volume":"137","author":"S Arimura","year":"2009","unstructured":"Arimura S, Matsunaga A, Kitamura T, Aoki K, Aoki M, Taketo MM. Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. Gastroenterology. 2009;137(2):629\u201338. https:\/\/doi.org\/10.1053\/j.gastro.2009.04.059.","journal-title":"Gastroenterology"},{"issue":"1","key":"4393_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/15384047.2014.972215","volume":"16","author":"L Song","year":"2015","unstructured":"Song L, Li ZY, Liu WP, Zhao MR. Crosstalk between Wnt\/\u03b2-catenin and Hedgehog\/Gli signaling pathways in colon cancer and implications for therapy. Cancer Biol Ther. 2015;16(1):1\u20137. https:\/\/doi.org\/10.4161\/15384047.2014.972215.","journal-title":"Cancer Biol Ther"},{"key":"4393_CR137","doi-asserted-by":"publisher","unstructured":"Szulzewsky F, Thirimanne HN, Holland EC. Meningioma: current updates on genetics, classification, and mouse modeling. Ups J Med Sci. 2024;129(S1):e10579. https:\/\/doi.org\/10.48101\/ujms.v129.10579.","DOI":"10.48101\/ujms.v129.10579"},{"issue":"6","key":"4393_CR138","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41588-024-01747-1","volume":"56","author":"CG Lucas","year":"2024","unstructured":"Lucas CG, Mirchia K, Seo K, Najem H, Chen WC, Zakimi N, Foster K, Eaton CD, Cady MA, Choudhury A, Liu SJ, Phillips JJ, Magill ST, Horbinski CM, Solomon DA, Perry A, Vasudevan HN, Heimberger AB, Raleigh DR. Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution. Nat Genet. 2024;56(6):1121\u201333. https:\/\/doi.org\/10.1038\/s41588-024-01747-1.","journal-title":"Nat Genet"},{"issue":"10","key":"4393_CR139","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.it.2018.08.006","volume":"39","author":"WJ Chae","year":"2018","unstructured":"Chae WJ, Bothwell ALM. Canonical and Non-Canonical Wnt Signaling in Immune Cells. Trends Immunol. 2018;39(10):830\u201347. https:\/\/doi.org\/10.1016\/j.it.2018.08.006.","journal-title":"Trends Immunol"},{"issue":"1","key":"4393_CR140","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11060-007-9500-6","volume":"87","author":"N Pe\u0107ina-Slaus","year":"2008","unstructured":"Pe\u0107ina-\u0160laus N, Niku\u0161eva Marti\u0107; T, Tomas D, Bero\u0161 V, Zeljko M, \u010cupi\u0107 H. Meningiomas exhibit loss of heterozygosity of the APC gene. J Neurooncol. 2008;87(1):63\u201370. https:\/\/doi.org\/10.1007\/s11060-007-9500-6.","journal-title":"J Neurooncol"},{"issue":"5","key":"4393_CR141","doi-asserted-by":"publisher","first-page":"a008052","DOI":"10.1101\/cshperspect.a008052","volume":"4","author":"P Polakis","year":"2012","unstructured":"Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4(5):a008052. https:\/\/doi.org\/10.1101\/cshperspect.a008052.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4393_CR142","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461\u201373. https:\/\/doi.org\/10.1038\/onc.2016.304.","journal-title":"Oncogene"},{"issue":"8","key":"4393_CR143","doi-asserted-by":"publisher","first-page":"14089","DOI":"10.18632\/oncotarget.12923","volume":"8","author":"Y Peng","year":"2017","unstructured":"Peng Y, Zhang X, Feng X, Fan X, Jin Z. The crosstalk between microRNAs and the Wnt\/\u03b2-catenin signaling pathway in cancer. Oncotarget. 2017;8(8):14089\u2013106. https:\/\/doi.org\/10.18632\/oncotarget.12923.","journal-title":"Oncotarget"},{"issue":"2","key":"4393_CR144","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1124\/mol.119.117978","volume":"97","author":"Z Zhong","year":"2020","unstructured":"Zhong Z, Virshup DM. Wnt Signaling and Drug Resistance in Cancer. Mol Pharmacol. 2020;97(2):72\u201389. https:\/\/doi.org\/10.1124\/mol.119.117978.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"4393_CR145","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.5001\/omj.2020.49","volume":"35","author":"A Jalilvand","year":"2020","unstructured":"Jalilvand A, Soltanpour MS. Promoter Hypermethylation of Wnt\/\u03b2-catenin Signaling Pathway Inhibitor WIF-1 Gene and its Association with MTHFR C677T Polymorphism in Patients with Colorectal Cancer. Oman Med J. 2020;35(3):e131. https:\/\/doi.org\/10.5001\/omj.2020.49.","journal-title":"Oman Med J"},{"key":"4393_CR146","doi-asserted-by":"publisher","first-page":"681053","DOI":"10.3389\/fgene.2021.681053","volume":"12","author":"A Sharma","year":"2021","unstructured":"Sharma A, Mir R, Galande S. Epigenetic Regulation of the Wnt\/\u03b2-Catenin Signaling Pathway in Cancer. Front Genet. 2021;12:681053. https:\/\/doi.org\/10.3389\/fgene.2021.681053.","journal-title":"Front Genet"},{"issue":"7","key":"4393_CR147","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/cells12070990","volume":"12","author":"W Groenewald","year":"2023","unstructured":"Groenewald W, Lund AH, Gay DM. The Role of Wnt Pathway Mutations in Cancer Development and an Overview of Therapeutic Options. Cells. 2023;12(7):990. https:\/\/doi.org\/10.3390\/cells12070990.","journal-title":"Cells"},{"issue":"1","key":"4393_CR148","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","volume":"24","author":"X Wu","year":"2025","unstructured":"Wu X, Que H, Li Q, Wei X. Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy. Mol Cancer. 2025;24(1):171. https:\/\/doi.org\/10.1186\/s12943-025-02363-1.","journal-title":"Mol Cancer"},{"issue":"1","key":"4393_CR149","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12943-025-02306-w","volume":"24","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation. Mol Cancer. 2025;24(1):107. https:\/\/doi.org\/10.1186\/s12943-025-02306-w.","journal-title":"Mol Cancer"},{"issue":"20","key":"4393_CR150","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.3390\/ijms21207697","volume":"21","author":"M Koni","year":"2020","unstructured":"Koni M, Pinnar\u00f2 V, Brizzi MF. The Wnt Signalling Pathway: A Tailored Target in Cancer. Int J Mol Sci. 2020;21(20):7697. https:\/\/doi.org\/10.3390\/ijms21207697.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4393_CR151","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"4393_CR152","doi-asserted-by":"publisher","first-page":"e35989","DOI":"10.1016\/j.heliyon.2024.e35989","volume":"10","author":"X Zhao","year":"2024","unstructured":"Zhao X, Ma Y, Luo J, Xu K, Tian P, Lu C, Song J. Blocking the WNT\/\u03b2-catenin pathway in cancer treatment: pharmacological targets and drug therapeutic potential. Heliyon. 2024;10(16):e35989. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35989.","journal-title":"Heliyon"},{"issue":"7","key":"4393_CR153","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/cancers13071633","volume":"13","author":"A Bukovac","year":"2021","unstructured":"Bukovac A, Kafka A, Ragu\u017e M, Brlek P, Dragi\u010devi\u0107 K, M\u00fcller D, Pe\u0107ina-\u0160laus N. Are we benign? What can Wnt signaling pathway and epithelial to mesenchymal transition tell us about intracranial meningioma progression. Cancers. 2021;13(7):1633. https:\/\/doi.org\/10.3390\/cancers13071633.","journal-title":"Cancers"},{"issue":"2","key":"4393_CR154","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3892\/ol.2025.15145","volume":"30","author":"L Jing","year":"2025","unstructured":"Jing L, Wang H, Xia S, Shao Q. Wnt\/Ca2\u2009+\u2009signaling: Dichotomous roles in regulating tumor progress (Review). Oncol Lett. 2025;30(2):399. https:\/\/doi.org\/10.3892\/ol.2025.15145.","journal-title":"Oncol Lett"},{"key":"4393_CR155","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/1471-2407-13-496","volume":"13","author":"H Bo","year":"2013","unstructured":"Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X, Zhu M. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. BMC Cancer. 2013;13:496. https:\/\/doi.org\/10.1186\/1471-2407-13-496.","journal-title":"BMC Cancer"},{"issue":"1","key":"4393_CR156","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/etm.2014.1676","volume":"8","author":"N Zhu","year":"2014","unstructured":"Zhu N, Qin L, Luo Z, Guo Q, Yang L, Liao D. Challenging role of Wnt5a and its signaling pathway in cancer metastasis (Review). Exp Ther Med. 2014;8(1):3\u20138. https:\/\/doi.org\/10.3892\/etm.2014.1676.","journal-title":"Experimental Therapeutic Med"},{"issue":"6","key":"4393_CR157","doi-asserted-by":"publisher","first-page":"BSR20171092","DOI":"10.1042\/BSR20171092","volume":"37","author":"B Wang","year":"2017","unstructured":"Wang B, Tang Z, Gong H, Zhu L, Liu X. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer. Biosci Rep. 2017;37(6):BSR20171092. https:\/\/doi.org\/10.1042\/BSR20171092.","journal-title":"Biosci Rep"},{"issue":"13","key":"4393_CR158","doi-asserted-by":"publisher","first-page":"e23737","DOI":"10.1096\/fj.202400436R","volume":"38","author":"Z Lei","year":"2024","unstructured":"Lei Z, Niu J, Cai H, Kong Z, Ding X, Dong Y, Zhang D, Li X, Shao J, Lin A, Zhou R, Yang S, Yan Q. NF2 regulates IP3R-mediated Ca2+ signal and apoptosis in meningiomas. FASEB J. 2024;38(13):e23737. https:\/\/doi.org\/10.1096\/fj.202400436R.","journal-title":"FASEB J"},{"issue":"1","key":"4393_CR159","doi-asserted-by":"publisher","first-page":"31992","DOI":"10.1038\/s41598-024-83553-7","volume":"14","author":"Z Lei","year":"2024","unstructured":"Lei Z, Cai H, Yan Q. NF2 can mediate the expression of CAMK2A in a tissue specific manner. Sci Rep. 2024;14(1):31992. https:\/\/doi.org\/10.1038\/s41598-024-83553-7.","journal-title":"Sci Rep"},{"issue":"2","key":"4393_CR160","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jdb12020012","volume":"12","author":"S Kacker","year":"2024","unstructured":"Kacker S, Parsad V, Singh N, Hordiichuk D, Alvarez S, Gohar M, , Kacker A, Rai SK. Planar Cell Polarity Signaling: Coordinated Crosstalk for Cell Orientation. J Dev Biol. 2024;12(2):12. https:\/\/doi.org\/10.3390\/jdb12020012.","journal-title":"J Dev Biology"},{"key":"4393_CR161","doi-asserted-by":"publisher","unstructured":"VanderVorst K, Dreyer CA, Konopelski SE, Lee H, Ho HH, Carraway KL 3rd. Wnt\/PCP Signaling Contribution to Carcinoma Collective Cell Migration and Metastasis. Cancer Res. 2019;79(8):1719\u201329. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2757.","DOI":"10.1158\/0008-5472.CAN-18-2757"},{"key":"4393_CR162","doi-asserted-by":"publisher","unstructured":"VanderVorst K, Dreyer CA, Hatakeyama J, Bell GRR, Learn JA, Berg AL, Hernandez M, Lee H, Collins SR, Carraway KL 3. Vangl-dependent Wnt\/planar cell polarity signaling mediates collective breast carcinoma motility and distant metastasis. Breast Cancer Res. 2023;25(1):52. https:\/\/doi.org\/10.1186\/s13058-023-01651-2.","DOI":"10.1186\/s13058-023-01651-2"},{"issue":"5","key":"4393_CR163","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.3892\/ol.2016.5063","volume":"12","author":"G Tate","year":"2016","unstructured":"Tate G, Kishimoto K, Mitsuya T. A novel mutation of the FAT2 gene in spinal meningioma. Oncol Lett. 2016;12(5):3393\u20136. https:\/\/doi.org\/10.3892\/ol.2016.5063.","journal-title":"Oncol Lett"},{"issue":"1","key":"4393_CR164","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1038\/s41467-020-18582-7","volume":"11","author":"ST Magill","year":"2020","unstructured":"Magill ST, Vasudevan HN, Seo K, Villanueva-Meyer JE, Choudhury A, John Liu S, Pekmezci M, Findakly S, Hilz S, Lastella S, Demaree B, Braunstein SE, Bush NAO, Aghi MK, Theodosopoulos PV, Sneed PK, Abate AR, Berger MS, McDermott MW, Lim DA, Ullian EM, Costello JF, Raleigh DR. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Nat Commun. 2020;11(1):4803. https:\/\/doi.org\/10.1038\/s41467-020-18582-7.","journal-title":"Nat Commun"},{"issue":"10","key":"4393_CR165","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1021\/acs.jproteome.5c00262","volume":"24","author":"A Halder","year":"2025","unstructured":"Halder A, Maitra A, Attrish D, Saha A, Biswas D, Dhamija B, Purwar R, Srivastava S. Molecular Profiling of Belumosudil-Treated IOMM-Lee Meningioma Cells Reveals Repurposing Potential via Enhanced Oxidative Phosphorylation and ROS-Mediated Cell Death. J Proteome Res. 2025;24(10):4935\u201351. https:\/\/doi.org\/10.1021\/acs.jproteome.5c00262.","journal-title":"J Proteome Res"},{"key":"4393_CR166","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cellsig.2018.03.004","volume":"47","author":"M Sharma","year":"2018","unstructured":"Sharma M, Castro-Piedras I, Simmons GE Jr, Pruitt K. Dishevelled: A masterful conductor of complex Wnt signals. Cell Signal. 2018;47:52\u201364. https:\/\/doi.org\/10.1016\/j.cellsig.2018.03.004.","journal-title":"Cell Signal"},{"issue":"21","key":"4393_CR167","doi-asserted-by":"publisher","first-page":"11996","DOI":"10.3390\/ijms222111996","volume":"22","author":"A Bukovac","year":"2021","unstructured":"Bukovac A, Dragi\u010devi\u0107 K, Kafka A, Ore\u0161kovi\u0107 D, Cesarec-Augustinovi\u0107 S, Pe\u0107ina-\u0160laus N. Decoding the Role of DVL1 in Intracranial Meningioma. Int J Mol Sci. 2021;22(21):11996. https:\/\/doi.org\/10.3390\/ijms222111996.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4393_CR168","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/cancers11111633","volume":"11","author":"S Lee","year":"2019","unstructured":"Lee S, Karas PJ, Hadley CC, Bayley VJC, Khan AB, Jalali A, Sweeney AD, Klisch TJ, Patel AJ. The Role of Merlin\/NF2 Loss in Meningioma Biology. Cancers (Basel). 2019;11(11):1633. https:\/\/doi.org\/10.3390\/cancers11111633.","journal-title":"Cancers (Basel)"},{"key":"4393_CR169","doi-asserted-by":"publisher","unstructured":"Norton E, Mewborne Q, Suarez-Meade P, Quinones-Hinojosa A, Clark V. CSIG-23. NF2\/MERLIN LOSS INDUCES UPREGULATION OF AN ALTERNATIVE WNT5A\/B SIGNALING PATHWAY SENSITIVE TO YAP INHIBITION. Neuro Oncol. 2025;27(Suppl 5):v89. https:\/\/doi.org\/10.1093\/neuonc\/noaf201.0357.","DOI":"10.1093\/neuonc\/noaf201.0357"},{"issue":"2","key":"4393_CR170","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/egjp.egjp_44_21","volume":"41","author":"RA Ibrahim","year":"2021","unstructured":"Ibrahim RA, Shash LS, Elgohary SA. FOXM1 and \u03b2-catenin in meningiomas: biomarkers for tumor proliferation and progression. Egypt J Pathol. 2021;41(2):137\u201345. https:\/\/doi.org\/10.4103\/egjp.egjp_44_21.","journal-title":"Egypt J Pathol"},{"issue":"8","key":"4393_CR171","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/neuonc\/nox018","volume":"19","author":"\u00dc Yesil\u00f6z","year":"2017","unstructured":"Yesil\u00f6z \u00dc, Kirches E, Hartmann C, Scholz J, Kropf S, Sahm F, Nakamura M, Mawrin C. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1\/2 activation and reduced time to tumor recurrence. Neuro Oncol. 2017;19(8):1088\u201396. https:\/\/doi.org\/10.1093\/neuonc\/nox018.","journal-title":"Neurooncology"},{"issue":"5","key":"4393_CR172","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/neuonc\/now029","volume":"18","author":"G Zadeh","year":"2016","unstructured":"Zadeh G, Karimi S, Aldape KD. PIK3CA mutations in meningioma. Neuro Oncol. 2016;18(5):603\u20134. https:\/\/doi.org\/10.1093\/neuonc\/now029.","journal-title":"Neurooncology"},{"issue":"2","key":"4393_CR173","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11060-025-05082-1","volume":"174","author":"M Abikenari","year":"2025","unstructured":"Abikenari M, Regev A, Himic V, Choi J, Jeyaretna S, Fountain DM, Lim M. The hormonal nexus in PIK3CA-mutated meningiomas: implications for targeted therapy and clinical trial design. J Neurooncol. 2025;174(2):329\u201340. https:\/\/doi.org\/10.1007\/s11060-025-05082-1.","journal-title":"J Neurooncol"},{"issue":"3","key":"4393_CR174","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s11064-016-2044-4","volume":"42","author":"E Majewska","year":"2017","unstructured":"Majewska E, Szeliga M. AKT\/GSK3\u03b2 Signaling in Glioblastoma. Neurochem Res. 2017;42(3):918\u201324. https:\/\/doi.org\/10.1007\/s11064-016-2044-4.","journal-title":"Neurochem Res"},{"issue":"2","key":"4393_CR175","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/iep.12186","volume":"97","author":"N Pe\u0107ina-\u0160laus","year":"2016","unstructured":"Pe\u0107ina-\u0160laus N, Kafka A, Vladu\u0161i\u0107 T, Tomas D, Logara M, Skoko J, Hra\u0161\u0107an R. Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression. Int J Exp Pathol. 2016;97(2):159\u201369. https:\/\/doi.org\/10.1111\/iep.12186.","journal-title":"Int J Exp Pathol"},{"key":"4393_CR176","doi-asserted-by":"publisher","first-page":"105211","DOI":"10.1016\/j.ebiom.2024.105211","volume":"105","author":"J Na","year":"2024","unstructured":"Na J, Shaji S, Hanemann CO. Targeting histone deacetylase 6 (HDAC6) to enhance radiation therapy in meningiomas in a 2D and 3D in vitro study. EBioMedicine. 2024;105:105211. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105211.","journal-title":"EBioMedicine"},{"issue":"1","key":"4393_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1827.2005.01786.x","volume":"55","author":"S Shimada","year":"2005","unstructured":"Shimada S, Ishizawa K, Hirose T. Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy. Pathol Int. 2005;55(1):1\u20137. https:\/\/doi.org\/10.1111\/j.1440-1827.2005.01786.x.","journal-title":"Pathol Int"},{"key":"4393_CR178","unstructured":"Utsuki S, Oka H, Sato Y, Kawano N, Tsuchiya B, Kobayashi I, Fujii K. Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin. Clin Neuropathol. 2005 ;24(1):8\u201312. PMID: 15696778."},{"issue":"2","key":"4393_CR179","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2559.2006.02440.x","volume":"49","author":"EC Brunner","year":"2006","unstructured":"Brunner EC, Romeike BFM, Jung M, Comtesse N, Meese E. Altered expression of beta-catenin\/E-cadherin in meningiomas. Histopathology. 2006;49(2):178\u201387. https:\/\/doi.org\/10.1111\/j.1365-2559.2006.02440.x.","journal-title":"Histopathology"},{"issue":"6","key":"4393_CR180","doi-asserted-by":"publisher","first-page":"e11231","DOI":"10.1371\/journal.pone.0011231","volume":"5","author":"K Zhou","year":"2010","unstructured":"Zhou K, Wang G, Wang Y, Jin H, Yang S, Liu C. The potential involvement of E-cadherin and beta-catenins in meningioma. PLoS ONE. 2010;5(6):e11231. https:\/\/doi.org\/10.1371\/journal.pone.0011231.","journal-title":"PLoS ONE"},{"issue":"9","key":"4393_CR181","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/00207454.2018.1424153","volume":"128","author":"R Rutkowski","year":"2018","unstructured":"Rutkowski R, Chrzanowski R, Trwoga M, Kochanowicz J, Turek G, Mariak Z, Resze\u0107 J. Expression of N-cadherin and \u03b2-catenin in human meningioma in correlation with peritumoral edema. Int J Neurosci. 2018;128(9):805\u201310. https:\/\/doi.org\/10.1080\/00207454.2018.1424153.","journal-title":"Int J Neurosci"},{"key":"4393_CR182","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12935-018-0571-6","volume":"18","author":"H Alamir","year":"2018","unstructured":"Alamir H, Alomari M, Salwati AAA, Saka M, Bangash M, Baeesa S, Alghamdi F, Carracedo A, Schulten HJ, Chaudhary A, Abuzenadah A, Hussein D. In situ characterization of stem cells-like biomarkers in meningiomas. Cancer Cell Int. 2018;18:77. https:\/\/doi.org\/10.1186\/s12935-018-0571-6.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4393_CR183","doi-asserted-by":"publisher","first-page":"319","DOI":"10.20892\/j.issn.2095-3941.2017.0024","volume":"14","author":"RA Ahmed","year":"2017","unstructured":"Ahmed RA, Shebl AM, Habashy HO. Expression levels of \u03b2-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray study. Cancer Biol Med. 2017;14(3):319\u201326. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2017.0024.","journal-title":"Cancer Biol Med"},{"issue":"10","key":"4393_CR184","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/NEN.0b013e31826bf704","volume":"71","author":"E P\u00e9rez-Mag\u00e1n","year":"2012","unstructured":"P\u00e9rez-Mag\u00e1n E, Campos-Mart\u00edn Y, Mur P, Fia\u00f1o C, Ribalta T, Garc\u00eda JF, Rey JA, Rodr\u00edguez de Lope A, Mollejo M, Mel\u00e9ndez B. Genetic alterations associated with progression and recurrence in meningiomas. J Neuropathol Exp Neurol. 2012;71(10):882\u201393. https:\/\/doi.org\/10.1097\/NEN.0b013e31826bf704.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"4393_CR185","doi-asserted-by":"publisher","first-page":"16432","DOI":"10.1038\/s41598-021-95956-x","volume":"11","author":"PJJ Damen","year":"2021","unstructured":"Damen PJJ, Bulthuis VJ, Hanssens PEJ, Lie ST, Fleischeuer R, Melotte V, Wouters KA, Ruland A, Beckervordersandforth J, Speel EJM. WHO grade I meningiomas that show regrowth after gamma knife radiosurgery often show 1p36 loss. Sci Rep. 2021;11(1):16432. https:\/\/doi.org\/10.1038\/s41598-021-95956-x.","journal-title":"Sci Rep"},{"key":"4393_CR186","doi-asserted-by":"publisher","first-page":"811729","DOI":"10.3389\/fonc.2022.811729","volume":"12","author":"M Millesi","year":"2022","unstructured":"Millesi M, Ryba AS, Hainfellner JA, Roetzer T, Berghoff AS, Preusser M, Heller G, Tomasich E, Sahm F, Roessler K, Wolfsberger S. DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case-Control Study. Front Oncol. 2022;12:811729. https:\/\/doi.org\/10.3389\/fonc.2022.811729.","journal-title":"Front Oncol"},{"issue":"9","key":"4393_CR187","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/neuonc\/noaf105","volume":"27","author":"P Sievers","year":"2025","unstructured":"Sievers P, Arora S, Hielscher T, Savran D, Schrimpf D, Banan R, Vonh\u00f6ren D, Pusch S, Sill M, Appay R, Wirsching HG, Hortobagyi T, Dohmen H, Acker T, Kohlhof-Meinecke P, Schweizer L, Wefers AK, Harter PN, Hartmann C, Beschorner R, Schittenhelm J, Behling F, Tabatabai G, Mawrin C, Snuderl M, Maas SLN, Wesseling P, Brandner S, Korshunov A, Ratliff M, Krieg SM, Wick W, Jones DTW, Pfister SM, Holland EC, von Deimling A, Szulzewsky F, Sahm F. Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes. Neuro Oncol. 2025;27(9):2326\u201340. https:\/\/doi.org\/10.1093\/neuonc\/noaf105.","journal-title":"Neuro Oncol"},{"issue":"3","key":"4393_CR188","doi-asserted-by":"publisher","first-page":"932","DOI":"10.18632\/aging.101201","volume":"9","author":"TV Werner","year":"2017","unstructured":"Werner TV, Hart M, Nickels R, Kim YJ, Menger MD, Bohle RM, Keller A, Ludwig N, Meese E. MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2. Aging (Albany NY). 2017;9(3):932\u201354. https:\/\/doi.org\/10.18632\/aging.101201.","journal-title":"Aging"},{"key":"4393_CR189","doi-asserted-by":"publisher","first-page":"108718","DOI":"10.1016\/j.biopha.2019.108718","volume":"113","author":"T Li","year":"2019","unstructured":"Li T, Ren J, Ma J, Wu J, Zhang R, Yuan H, Han X. LINC00702\/miR-4652-3p\/ZEB1 axis promotes the progression of malignant meningioma through activating Wnt\/\u03b2-catenin pathway. Biomed Pharmacother. 2019;113:108718. https:\/\/doi.org\/10.1016\/j.biopha.2019.108718.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4393_CR190","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/jcb.29423","volume":"121","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yu R, Li Q, Li Y, Xuan T, Cao S, Zheng J. SNHG1\/miR-556-5p\/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway. J Cell Biochem. 2020;121(2):1880\u20139. https:\/\/doi.org\/10.1002\/jcb.29423.","journal-title":"J Cell Biochem"},{"key":"4393_CR191","doi-asserted-by":"publisher","unstructured":"Das A, Miller R, Lee P, Holden CA, Lindhorst SM, Jaboin J, Vandergrift WA 3rd, Banik NL, Giglio P, Varma AK, Raizer JJ, Patel SJ. A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt\/\u03b2-catenin signaling pathway. Tumour Biol. 2015;36(9):7027\u201334. https:\/\/doi.org\/10.1007\/s13277-015-3388-0.","DOI":"10.1007\/s13277-015-3388-0"},{"issue":"2","key":"4393_CR192","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s12276-020-0380-6","volume":"52","author":"YS Jung","year":"2020","unstructured":"Jung YS, Park JI. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond \u03b2-catenin and the destruction complex. Exp Mol Med. 2020;52(2):183\u201391. https:\/\/doi.org\/10.1038\/s12276-020-0380-6.","journal-title":"Exp Mol Med"},{"issue":"7","key":"4393_CR193","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.3390\/ijms24076733","volume":"24","author":"N Pe\u0107ina-\u0160laus","year":"2023","unstructured":"Pe\u0107ina-\u0160laus N, Ani\u010di\u0107 S, Bukovac A, Kafka A. Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment. Int J Mol Sci. 2023;24(7):6733. https:\/\/doi.org\/10.3390\/ijms24076733.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4393_CR194","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5603\/njo.97607","volume":"73","author":"R Pacholczak-Madej","year":"2023","unstructured":"Pacholczak-Madej R, Fr\u0105czek P, Skrzypek K, P\u00fcsk\u00fcll\u00fco\u011flu M. Wnt pathways in focus \u2013 mapping current clinical trials across the cancer spectrum. Nowotwory J Oncol. 2023;73(6):370\u201380. https:\/\/doi.org\/10.5603\/njo.97607.","journal-title":"Nowotwory J Oncol"},{"issue":"7","key":"4393_CR195","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/ph17070949","volume":"17","author":"A de Pellegars-Malhortie","year":"2024","unstructured":"de Pellegars-Malhortie A, Picque Lasorsa L, Mazard T, Granier F, Pr\u00e9vostel C. Why Is Wnt\/\u03b2-Catenin Not Yet Targeted in Routine Cancer Care? Pharmaceuticals (Basel). 2024;17(7):949. https:\/\/doi.org\/10.3390\/ph17070949.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"4393_CR196","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4233","volume":"13","author":"M Kahn","year":"2014","unstructured":"Kahn M. Can we safely target the Wnt pathway? Nat Rev Drug Discovery. 2014;13(7):513\u201332. https:\/\/doi.org\/10.1038\/nrd4233.","journal-title":"Nat Rev Drug Discovery"},{"issue":"4","key":"4393_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/RRBC.S53823","volume":"2014","author":"YM Kim","year":"2014","unstructured":"Kim YM, Kahn M. The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development. Res Rep Biochem. 2014;2014(4):1\u201312. https:\/\/doi.org\/10.2147\/RRBC.S53823.","journal-title":"Res Rep Biochem"},{"issue":"4","key":"4393_CR198","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"EH Jho","year":"2002","unstructured":"Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22(4):1172\u201383. https:\/\/doi.org\/10.1128\/MCB.22.4.1172-1183.2002.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"4393_CR199","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11060-010-0367-6","volume":"99","author":"D Saloner","year":"2010","unstructured":"Saloner D, Uzelac A, Hetts S, Martin A, Dillon W. Modern meningioma imaging techniques. J Neurooncol. 2010;99(3):333\u201340. https:\/\/doi.org\/10.1007\/s11060-010-0367-6.","journal-title":"J Neurooncol"},{"key":"4393_CR200","doi-asserted-by":"publisher","first-page":"e70992","DOI":"10.7554\/eLife.70992","volume":"10","author":"BD Gastfriend","year":"2021","unstructured":"Gastfriend BD, Nishihara H, Canfield SG, Foreman KL, Engelhardt B, Palecek SP, Shusta EV. Wnt signaling mediates acquisition of blood-brain barrier properties in na\u00efve endothelium derived from human pluripotent stem cells. eLife. 2021;10:e70992. https:\/\/doi.org\/10.7554\/eLife.70992.","journal-title":"eLife"},{"key":"4393_CR201","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jconrel.2024.03.047","volume":"369","author":"R Mu","year":"2024","unstructured":"Mu R, Sun H, Zeng Y, Tong Y, Tang P, Zhao M, Lv Z, Yu J, Chen Y, Lan Q, Zhen X, Han L. Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy. J Control Release. 2024;369:458\u201374. https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.047.","journal-title":"J Control Release"},{"issue":"2","key":"4393_CR202","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s13311-017-0520-4","volume":"14","author":"AM Mehta","year":"2017","unstructured":"Mehta AM, Sonabend AM, Bruce JN. Convection-Enhanced Delivery. Neurotherapeutics. 2017;14(2):358\u201371. https:\/\/doi.org\/10.1007\/s13311-017-0520-4.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"4393_CR203","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1208\/s12248-008-9009-8","volume":"10","author":"J Rautio","year":"2008","unstructured":"Rautio J, Laine K, Gynther M, Savolainen J. Prodrug approaches for CNS delivery. AAPS J. 2008;10(1):92\u2013102. https:\/\/doi.org\/10.1208\/s12248-008-9009-8.","journal-title":"AAPS J"},{"key":"4393_CR204","doi-asserted-by":"publisher","first-page":"113595","DOI":"10.1016\/j.jconrel.2025.113595","volume":"381","author":"H Baghirov","year":"2025","unstructured":"Baghirov H. Mechanisms of receptor-mediated transcytosis at the blood-brain barrier. J Control Release. 2025;381:113595. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113595.","journal-title":"J Control Release"},{"issue":"6","key":"4393_CR205","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/pharmaceutics17060706","volume":"17","author":"L Ding","year":"2025","unstructured":"Ding L, Kshirsagar P, Agrawal P, Murry DJ. Crossing the Blood-Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies. Pharmaceutics. 2025;17(6):706. https:\/\/doi.org\/10.3390\/pharmaceutics17060706.","journal-title":"Pharmaceutics"},{"issue":"11","key":"4393_CR206","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/neuonc\/noab155","volume":"23","author":"S Yamazaki","year":"2021","unstructured":"Yamazaki S, Ohka F, Hirano M, Shiraki Y, Motomura K, Tanahashi K, Tsujiuchi T, Motomura A, Aoki K, Shinjo K, Murofushi Y, Kitano Y, Maeda S, Kato A, Shimizu H, Yamaguchi J, Adilijiang A, Wakabayashi T, Saito R, Enomoto A, Kondo Y, Natsume A. Newly established patient-derived organoid model of intracranial meningioma. Neuro Oncol. 2021;23(11):1936\u201348. https:\/\/doi.org\/10.1093\/neuonc\/noab155.","journal-title":"Neuro Oncol"},{"issue":"3","key":"4393_CR207","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/cancers17030526","volume":"17","author":"YM Zohdy","year":"2025","unstructured":"Zohdy YM, Jahangiri A, Jacob F, Aksionau A, Alawieh AM, Tong A, Chern B, Maldonado J, Hoang K, Nduom E, Howard BM, Barrow DL, Neill SG, Wen Z, Pradilla G, Garzon-Muvdi T. Patient-Derived Meningioma Organoids: A Reliable Model for Studying Human Tumor Pathophysiology. Cancers (Basel). 2025;17(3):526. https:\/\/doi.org\/10.3390\/cancers17030526.","journal-title":"Cancers (Basel)"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04393-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04393-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04393-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:59:09Z","timestamp":1792555149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04393-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4393"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04393-1","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"345"}}